avelumab
ItalyDrugs containing this active substance
-
It is used in adults for the treatment of metastatic Merkel cell carcinoma, advanced or metastatic urothelial carcinoma (as maintenance treatment after platinum-based chemotherapy), and advanced renal cell carcinoma (in combination with axitinib).
Form: solution for infusion, concentrate
Active substance Dosage avelumab - ATC: L01FF04
Manufacturer: MERCK EUROPE B.V.